Form 4: Labcorp CEO Plans Future Stock Sale Under 10b5-1 Plan

Labcorp Holdings Inc. President and CEO Adam H. Schechter reported a planned sale of 5,643 shares of common stock for $266.78 per share, scheduled for August 11, 2025, under a Rule 10b5-1 plan.

Summary

• Adam H. Schechter, President & CEO and Director of Labcorp Holdings Inc., reported a planned disposition of common stock.
• The transaction is scheduled to occur on August 11, 2025.
• The planned sale involves 5,643 shares of common stock.
• The shares are to be sold at a price of $266.78 per share.
• The disposition is pursuant to a Rule 10b5-1 plan, indicating a pre-arranged trading schedule.
• Following this planned transaction, Schechter is expected to directly own 93,319 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan, which is generally considered a neutral event as it is not indicative of new material information.

Stakeholder Impact

• Minimal direct impact on shareholders as it's a pre-planned executive sale under a 10b5-1 plan, which is a common practice for executive financial management and not typically indicative of new company-specific news.

Key Dates

Recommendation

This Form 4 filing reports a future, pre-scheduled sale of shares by an executive under a Rule 10b5-1 plan. Such planned transactions are routine for executive financial management and do not typically reflect new material information about the company's performance or outlook. Therefore, this filing alone does not provide a basis for changing an investment recommendation.

Keywords

Labcorp, LH, Insider Trading, Form 4, Stock Sale, Executive Compensation, 10b5-1 Plan, Adam Schechter